Clinical Trials Browser

NIH × Urinary Bladder Neoplasms × Genistein × Clear all

NCT00118040 2021-06-10

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Phase 2 Completed

60 enrolled 24 charts

Urinary Bladder Neoplasms